Potential game changer for treatment and containment
A new test can accurately diagnose Ebola virus disease within minutes, providing clinicians with crucial information for treating patients and containing outbreaks.
Researchers from Harvard Medical School, Partners In Health and Boston Children’s Hospital have shown that a new commercially developed rapid diagnostic test performed at bedside was as sensitive as the conventional laboratory-based method used for clinical testing during the recent outbreak in Sierra Leone. The results are published in The Lancet.
While the West African Ebola epidemic has slowed since its peak last fall, the crisis simmers on; there were still 24 confirmed cases of Ebola reported in Guinea and Sierra Leone in the week ending June 14.
To fight Ebola, the first step is to determine which patients are sick with the disease and which with other illnesses with a similar presentation. To use the currently recommended molecular approach, laboratories must be built and samples of highly infectious blood must be drawn, often with unsafe needles and syringes, and then shipped over potentially great distances at substantial risk to the health care workers involved in the process. Then, clinicians and patients must wait for results–sometimes for several days.
These obstacles and delays prevent timely diagnosis and treatment, and also result in individuals without Ebola being admitted to holding units where they may become infected with the virus, the researchers said.
“Simplifying the process and speeding up diagnosis could have a major impact,” said Nira Pollock, senior author of the paper and HMS assistant professor of medicine and associate medical director of the Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital.
As the Ebola outbreak in West Africa began to surge in 2014, Pollock and Partners In Health researcher Jana Broadhurst worked with the research core of the HMS Department of Global Health and Social Medicine to reach out to teams around the world who were developing diagnostic tools that would enable clinicians to diagnose Ebola patients quickly.
One candidate, the ReEBOV Antigen Rapid Test, developed by Corgenix, seemed like a promising tool. Working with colleagues at Partners In Health and the Ministry of Health and Sanitation in Sierra Leone, the HMS team was able to plug into an environment that allowed it to train local technicians to perform the test and help collect data for the study. The team at the Public Health England lab at Port Loko, where clinical samples were routinely sent for standard molecular diagnostic testing, were also key collaborators. Corgenix donated test kits to the HMS team.
The field trial took place at two treatment centers operated by the Ministry of Health and Sanitation of Sierra Leone and supported by PIH, where 106 patients suspected of having Ebola were tested during February 2015 using the rapid diagnostic test (performed on a fingerstick blood sample at the point of care). The patients were also tested using the standard RT-PCR (performed on plasma in the laboratory). Both rapid diagnostic tests, on whole blood, and RT-PCR, on plasma, were also performed on 284 samples in the laboratory.
The rapid diagnostic test detected all confirmed cases of Ebola that were positive by the benchmark test in both point-of-care and laboratory testing with sensitivity of 100 percent (identifying all patients with Ebola found by the benchmark method), and a specificity of 92 percent (few false positives).
Surprisingly, the study also showed that the standard RT-PCR test, under the conditions deployed in the field, was itself an imperfect reference standard.
Both tests failed to detect a small number of Ebola cases that had been detected by an alternative lab test that was more sensitive than the benchmark test but was not available for wide usage. All of the missed cases showed very low levels of virus. The authors caution that given the limitations of the performance of the benchmark RT-PCR reference test in patients with low levels of the virus, more research is needed to assess how the new rapid diagnostic test will perform in patients still in the early stages of Ebola virus disease.
The Latest on: Rapid Ebola diagnostic
via Google News
The Latest on: Rapid Ebola diagnostic
- Sequencing and COVID-19: From Genomic Epidemiology to Host Responseon July 1, 2021 at 11:16 am
From the early stages of the emergence of SARS-CoV-2, researchers have used real-time nanopore sequencing to generate and share genetic data critical to understanding the virus and informing public ...
- Point Of Care (PoC) Molecular Diagnostics Market 2021 Key Trends, Opportunities & Forecasts To 2027on June 30, 2021 at 2:31 am
Mentioned below of few of the trends gaining in this industry: Some of the key players operating in the PoC molecular diagnostics industry include Cepheid (Danaher Corporation), Bio-Rad Laboratories, ...
- Researchers in the United States have developed a Covid detection mask.on June 30, 2021 at 1:30 am
Researchers from the Massachusetts Institute of Technology and Harvard University, in the United States, have developed a mask that can diagnose the SARS-CoV-2 virus, which causes Covid-19, in about ...
- Ebola Outbreak in Guinea Declared Overon June 23, 2021 at 8:01 pm
The U.S. Centers for Disease Control and Prevention (CDC) celebrates Saturday’s announcement by the Republic of Guinea (Guinea) Ministry of Health and the World Health Organization that the Ebola ...
- Paul Farmer on chronic roots of acute health criseson June 23, 2021 at 11:42 am
Paul Farmer, chair of the Department of Global Health and Social Medicine in the Blavatnik Institute at Harvard Medical School, was not planning to ...
- Irrigating the Clinical Deserton June 23, 2021 at 5:00 am
Ibrahim and I became friends, and he started working with us at Partners In Health, which had launched clinical services in Sierra Leone and Liberia that fall. My job during the epidemic was to take ...
- COVID-19 Puts the World Health Organization’s Emergency Use Listing (EUL) to Workon June 20, 2021 at 4:59 pm
However, it was apparent that there was an acute need for the rapid assessment of simple devices ... With a virus like Ebola, there’s extraordinarily little tolerance for a wrong diagnosis. If a ...
- Advancing Rapid Point-of-care Viral Diagnostics to a Clinical Settingon June 20, 2021 at 4:59 pm
The example of the western Africa Ebola outbreak highlights two important ... leading to better outcomes and reduced drug resistance. RDT: Rapid diagnostic test.
- Guinea declares end to Ebola outbreak that killed 12on June 19, 2021 at 7:22 am
CONAKRY -- An Ebola outbreak which started in southeast ... "Based on the lessons learned from the 2014–16 outbreak and through rapid, coordinated response efforts... Guinea managed to control ...
- WHO declares end to second Ebola outbreak in Guineaon June 19, 2021 at 6:25 am
“Based on the lessons learned from the 2014–16 outbreak and through rapid ... around vaccination for Ebola and contain transmissions using really effective diagnostic approaches,” Sterghios ...
via Bing News